
US backs ongoing Armenia-Azerbaijan peace efforts
10 July 23:52
Home page Health |
![]() ![]() ![]() ![]() |
The World Health Organization (WHO) has stopped testing hydroxychloroxine (an anti-malarial drug) and lopinavir / ritonavir (an antiretroviral drug) in hospitalized patients with a coronavirus diagnosis.
Axar.az informs that, preliminary test results showed that hydroxychloroxine and lopinavi / ritonavir did not, or almost did not, reduce mortality among hospitalized patients with COVID-19.
Date
2020.07.05 / 09:53
|
Author
Nurlana Ahmadova
|